Hyris støtter forskere og udviklere til at lancere testkit via nye onboarding-programmer

LONDON, UK / ACN Newswire / 27. september 2023 / I en tidsalder med tidlig masseudbredelse af tilgængelige AI-løsninger hævder mange specialister og forskere fra forskellige videnskabelige, tekniske og akademiske områder, at AI endnu ikke er nået langt nok. Ifølge en nyligt redaktionelt udgivet i Nature, several research fields which need accurate and accessible data won’t achieve their full potential until they integrate adequate machine-learning systems.

Hyris Onboarding-programmer Med Hyris kan både etablerede og nye testudviklere optimere deres go-to-market ved at udnytte kraften i AI.

Selvom AI-værktøjer lover en forstyrrelse i den måde, forskere søger og syntetiserer nyttige nye stoffer og tests på, er vi langt fra en engrosrevolution endnu, også på grund af manglen på data, der er tilgængelige til at fodre centraliserede AI-systemer. Dette stiller forskere og kitudviklere adskillige udfordringer med at designe og levere nye testløsninger.

Hyris holder fast i sin vision, at demokratisere genetik og sundhedsindsigt, og markerer et nyt stadie i sine partnerskabspolitikker med nymodens onboarding-programmer, der er specielt designet til yderligere at støtte forskere og kit-udviklere på alle stadier.

“Genetic test developing and onboarding has always been faced with inherent challenges, from resource staffing to competence integration, from research funding to ensuring adequate testing volumes,” states Angelica Baccanelli, Head of Quality & Regulation at Hyris. “Adapting to variability in the compliance environment, applying requirements to molecular assays, and developing the proper documentation for the go-to-market can all pose additional risks.”

Blandt mange udfordringer er teknologiske adgangshuller stadig den største hindring for udviklingen af ​​nye løsninger på tværs af forskellige brancher. Hyris står til at ændre dette til det bedre ved at udnytte AI-kapaciteterne i sin unikke genetiske testplatform, kendt verden over for dets AI-egenskaber sammen med dets unikke egenskaber af portabilitet, tilgængelighed og alsidighed.

“Researchers and kit developers know well how hard delivering new analytical solutions can be,” continues Baccanelli. “That’s why we increased our commitment to support both emerging players and established manufacturers performing beyond their current analytical capability via new onboarding programs.” Baccanelli goes on, depicting the advantages of such an inclusive approach. “We provide access to our technology and support developers through various stages of the development of new tests via proper education and technical assistance. This win-win approach enables any player to quickly integrate their portfolio with new products and solutions, maximizing their cost per value strategy.”

Hyris’s Onboarding strategy is proving successful across many industries. Such is the case of Luminis, Water Technologies, a leader in microbiome profiling and treatment solutions, which embraced Hyris’ Program to bring on-site qPCR diagnostics to the aquaculture industry, enabling customers to quickly and accurately test for pathogens, viruses, and bacteria, ultimately improving their operations’ overall safety and productivity in such industry. Luminis adopted the Hyris system to develop new qPCR diagnostics kits, enabling its customers to perform genetic analysis on-site rather than sending samples to a lab, significantly reducing turnaround time and allowing for more informed decision-making. Additionally, on-site testing eliminates the need for expensive lab equipment, and operators can now perform testing with minimal training.

“The benefits of on-site qPCR diagnostics are numerous,” explains Lorenzo Colombo, CTO at Hyris, “ensuring faster turnaround time and reduced costs, compared to centralized diagnostic systems. On the other hand, the downsides of such an approach have been the lack of accuracy and the complexity of on-site technologies, making this approach less suitable for day-to-day operations until now. We fixed all these problems, providing highly accurate results whilst requiring minimal training to operate. Hyris can really be used in any setting, even under the harshest conditions.”

Hyris’ distributed technology allows the identification of new and arising needs, even from decentralized areas: this, in turn, enables the design and deployment of fitting solutions at a very early stage of any diagnostic trend, throughout various diverse use cases. Kit developers and lab specialists can now truly collaborate, tapping into different levels of data analysis in real-time to bring innovative tests with superior quality and increased fitness to market; dressing on the cake, all the more quickly and efficiently.

“Too often, centralized diagnostic paradigms risk overlooking local needs, preventing benefits from being shared equitably,” sums up Stefano Lo Priore, co-founder and CEO at Hyris. “This also poses an ethical question, as innovations often fail to benefit those who need them most. Reliable portable diagnostic systems are key to building new capabilities for established and emerging diagnostic service providers. By helping others to deliver their solutions, we also fulfil our mission, generating a much wider impact worldwide.”

De nye Onboarding-programmer bidrager til at gøre Hyris til det første valg for testlaboratorier, testudviklere og forskere, der ønsker at udføre specifikke tests, der involverer mindre prøvearrays, reduceret tid til resultater og øget effektivitet og rentabilitet.

For at finde ud af, hvordan du udfører ud over din nuværende diagnostiske evne, er du velkommen til at kontakte en Hyris-ekspert på info@hyris.net.

Kontaktinformation

Gabriele Salaris, Global Experience Manager, gabriele.salaris@hyris.net +39 345 555 3379

Emne: Pressemeddelelsesoversigt
Kilde: Hyris
Sektorer: BioTech, Sundhedspleje & Farm
https://www.acnnewswire.com

Fra Asia Corporate News Network

Ophavsret © 2023 ACN Newswire. Alle rettigheder forbeholdes. En division af Asia Corporate News Network.

• SEO Powered Content & PR Distribution. Bliv forstærket i dag.
• PlatoData.Network Vertical Generative Ai. Styrk dig selv. Adgang her.
• PlatoAiStream. Web3 intelligens. Viden forstærket. Adgang her.
• PlatoESG. Kulstof, CleanTech, Energi, Miljø, Solenergi, Affaldshåndtering. Adgang her.
• PlatoHealth. Bioteknologiske og kliniske forsøgs intelligens. Adgang her.
• Kilde: https://www.acnnewswire.com/press-release/english/86737/